Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Patients with COVID-19 and Pre-Existing Heart Failure: A Single-Center Cohort Study
Journal of Clinical Medicine · 13.03.2026 · 15 (6) · 2209
DOI: 10.3390/jcm15062209 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.03.2026. Verfasst von Maria-Laura Craciun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babeș University of Medicine and Pharmacy Timișoara, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background/Objectives: Patients with pre-existing heart failure (HF) represent a clinically vulnerable population with increased susceptibility to adverse outcomes during acute systemic illnesses, including coronavirus disease 2019 (COVID-19). Systemic inflammation is increasingly recognized as a central pathophysiological mechanism linking cardiovascular vulnerability with infection-related organ dysfunction. However, the prognostic role of inflammatory biomarkers in hospitalized COVID-19 patients with pre-existing HF remains incompletely defined. This study aimed to evaluate the association between inflammatory biomarkers and clinical outcomes in this high-risk population.
Methods
This retrospective single-center cohort study included 395 consecutive adult patients hospitalized with confirmed COVID-19 between March 2020 and December 2024 at a tertiary referral center. Pre-existing HF was documented in 143 patients (36.2%). Inflammatory biomarkers, including C-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin, and D-dimer, were measured at admission. The primary outcomes were development of sepsis and in-hospital mortality. Multivariable logistic regression models were constructed to identify independent predictors of adverse outcomes after adjustment for demographic characteristics, comorbidities, disease severity, and cardiac biomarkers.
Results
Patients with pre-existing HF had significantly higher in-hospital mortality compared with those without HF (11.9% vs. 4.8%, p = 0.016) and showed a trend toward increased intensive care unit admission. HF patients exhibited higher admission IL-6 levels, indicating enhanced inflammatory activation. In univariable analysis, HF was associated with mortality (OR 2.67, 95% CI 1.22–5.83, p = 0.014). After multivariable adjustment, the association between HF and mortality was attenuated, whereas IL-6 remained an independent predictor of mortality (adjusted OR 1.38, 95% CI 1.04–1.82, p = 0.021). Elevated IL-6 and procalcitonin levels were also independently associated with sepsis development.
Conclusions
Pre-existing heart failure identifies a population at increased risk of adverse outcomes in hospitalized COVID-19 patients, and this excess risk appears to be partly mediated by systemic inflammatory activation. Interleukin-6 emerged as a key biomarker linking cardiovascular vulnerability, immune dysregulation, and clinical deterioration. These findings support the potential role of inflammation-based risk stratification to improve prognostic assessment and guide personalized management in high-risk patients with underlying cardiovascular disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of Internal Medicine I, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of General Medicine, Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of Public Health and Sanitary Management, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Centre for Translational Research and Systems Medicine, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of Clinic Nursing, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
ORCID-Profile: Adina Cristiana Avram, Diana-Maria Mateescu, Claudia Raluca Balasa Virzob, Simina Crisan, Florina Buleu, Daian Ionel Popa, Zorin Petrisor Crainiceanu
Förderung
- Victor Babeș University of Medicine and Pharmacy Timișoara
- Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania
Zitieren
APA
Craciun, M. L., Avram, A. C., Pah, A. M., Vacarescu, C., Mateescu, D. M., Ilie, A. C., Cotet, I. G., Virzob, C. R. B., Crisan, S., Avram, C., Buleu, F., Popa, D. I., Crainiceanu, Z. P., & Iurciuc, S. (2026). Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Patients with COVID-19 and Pre-Existing Heart Failure: A Single-Center Cohort Study. Journal of Clinical Medicine, 15(6), 2209. https://doi.org/10.3390/jcm15062209
Vancouver
Craciun ML, Avram AC, Pah AM, Vacarescu C, Mateescu DM, Ilie AC, et al. Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Patients with COVID-19 and Pre-Existing Heart Failure: A Single-Center Cohort Study. Journal of Clinical Medicine. 2026;15(6):2209. doi:10.3390/jcm15062209
BibTeX
@article{Craciun2026,
author = {Craciun, Maria-Laura and Avram, Adina Cristiana and Pah, Ana-Maria and Vacarescu, Cristina and Mateescu, Diana-Maria and Ilie, Adrian Cosmin and Cotet, Ioana Georgiana and Virzob, Claudia Raluca Balasa and Crisan, Simina and Avram, Claudiu and Buleu, Florina and Popa, Daian Ionel and Crainiceanu, Zorin Petrisor and Iurciuc, Stela},
title = {Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Patients with COVID-19 and Pre-Existing Heart Failure: A Single-Center Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {6},
pages = {2209},
doi = {10.3390/jcm15062209}
}
EUVIMED